ThaoPDangMD
Oncology • Charlottesville, VAAssociate Professor, Internal Medicine, University of Virginia School of Medicine
Are you Dr. Dang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4 Hospital Dr
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-243-6086
Summary
- Dr. Thao Dang, MD is an oncologist in Charlottesville, Virginia. She is currently licensed to practice medicine in Virginia. She is affiliated with University of Virginia Medical Center and is an Associate Professor at University of Virginia School of Medicine.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 2000
Emory University School of MedicineResidency, Internal Medicine, 1993 - 1996
MCP-Hahnemann College of MedicineClass of 1993
Certifications & Licensure
VA State Medical License 2010 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
- Study of Use of CTC in NSCLC Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- 87 citationsConstitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic miceThao P. Dang, Shannon Eichenberger, Adriana Gonzalez, Sandra J. Olson, David P. Carbone
Oncogene. 2003-04-03 - 46 citationsInhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in ...Lavinia Raimondi, Roberta Ciarapica, M De Salvo, Federica Verginelli, Marie Gueguen
Cell Death and Differentiation. 2012-05-01 - 33 citationsCloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitroNobuhiro Haruki, Keiko S. Kawaguchi, S Eichenberger, Pierre P. Massion, Adriana Gonzalez
Journal of Medical Genetics. 2005-07-01
